Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Phase II Study of Oxaliplatin and Navelbine for Second-Line Treatment of Advanced NSCLC.

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified October 2005 by Integrated Community Oncology Network.
Recruitment status was:  Not yet recruiting
Sponsor:
Collaborator:
Sanofi
Information provided by:
Integrated Community Oncology Network
ClinicalTrials.gov Identifier:
NCT00238849
First received: October 12, 2005
Last updated: October 13, 2005
Last verified: October 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Study Completion Date: No date given
  Primary Completion Date: No date given